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Introduction
　Atrial brillation （AF） is the most common cardiac arrhythmia.  Jais et al 1, 2） concluded 
that premature atrial contractions （PACs） from the pulmonary veins leads to AF and that 
radiofrequency （RF） ablation of those PACs is effective in preventing AF.  Since then, 
pulmonary vein isolation （PVI） is widely performed as a curative therapy for AF.
　When AF occurs frequently or lasts for a long duration, structural remodeling as well 
as electrical remodeling will occur in the atrial muscle 3）.  PVI should restore and maintain 
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Abstract : Background : Pulmonary vein isolation （PVI） is expected to cure 
atrial brillation （AF） and to improve atrial remodeling.  However, the effects 
of PVI on the right atrial （RA） size have not been fully examined.  We 
studied the effects of PVI on RA size in comparison that with the effects on 
LA size. 
　Method : We studied 17 patients with drug-refractory AF （11 paroxysmal, 6 
persistent）.  Two-dimensional echocardiography was performed at baseline and 
at follow-up to measure and compare RA and LA size.
　Results : Despite a short duration of AF in 7 patients after the PVI, all 
cases were maintained in sinus rhythm during the follow-up.  LA and RA size 
were both reduced after the PVI compared with baseline measurements （LA 
25.5 ± 2.9 cm2 vs. 23.2 ± 3.6 cm2, P＜ 0.05, RA 21.2 ± 2.9 cm2 vs. 18.1 ± 3.0 cm2, 
P＜ 0.01）.  The reduction ratio was more prominent in RA size （14.9%） than 
in LA size （8.7%） （P＜ 0.05）. 
　Conclusion : Atrial size was reduced following PVI for both the LA and 
RA, although the rate of reduction was more prominent in the RA.
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sinus rhythm, and it is thought to result in improved atrial function or an atrial volume 
reduction 4-10）.  However, these previous studies were mainly focused on the left atrium 
（LA）, and the changes in the right atrium （RA） following PVI have not been fully evalu-
ated 9, 10）.  This study therefore examined the changes in both LA and RA size following 
PVI and compared the effect of the PVI on both atria.  
Methods
Study patients
　Seventeen patients （14 men ; age 63.9 ± 11.9 years, range 37-77 years） with drug-refractory 
non-valvular paroxysmal （PAF ; n＝ 11） or persistent （PER-AF ; n＝ 6） AF were studied. 
Table 1 details the patient characteristics.  The average AF history was 5.3 ± 8.3 years, with 
cases of hypertension the most prevalent （76.5%）.  Selected patients were taking prescribed 
oral medications, including angiotensin receptor blocker （ARB）/angiotensin-converting 
enzyme inhibitor （ACE-I） agents and statins, and these regimens were not changed during 
the follow-up.  The anti-arrhythmic drugs were not stopped at the time of the PVI proce-
dure, and were only discontinued at the follow-up visit if no AF recurrence was observed. 
Table 1.  Characteristics of the study patients
M/F（％）
Age（years）
Duration of AF（years）
Duration of echo after PVI（months）
Type of AF
　Paroxysmal（％）
　Persistent（％）
Recurrence（％）
PVI rst/second（％）
Ischemic heart disease（％）
Hyper thyroid（％）
Hypertension（％）
Dyslipidemia（％）
Diabetes（％）
Chronic heart disease（％）
Anti-arrhythmic drugs
　IC（％）
　IV（％）
　β-Blocker（％）
　ACE-I and/or ARB（％）
　Statin（％）
Patients（N＝ 17）
14（82.3）/ 3（17.7）
63.9 ± 11.9
5.3 ± 8.3
12.4 ± 3.0
11（64.7）
 6（35.3）
 7（41.2）
15（88.2）/ 2（11.8）
 2（11.8）
0  　　
13（76.5）
 5（29.4）
 4（23.5）
 2（11.8）
 5（29.4）
 8（47.1）
 5（29.4）
11（64.7）
 5（29.4）
ACE-I, angiotensin-converting enzyme inhibitor ; ARB, angiotensin 
receptor blocker ; AF, atrial blilation.
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AF recurrence was dened as AF lasting for more than 30 sec recorded on a Holter ECG, 
mobile ECG, or 12-lead ECG in the clinic.  The classication of AF was based on the 
ACC/AHA/ESC guidelines 11）.
Echocardiography
　Transthoracic echocardiography was performed in all patients at baseline and at 12 months 
after the PVI.  They were done by two skilled sonographers and one doctor.  We acquired 
several recordings from each view and performed measurements on the best images.  All 
measurements were acquired in sinus rhythm.  The apical long axis view was used to mea-
sure both atrial sizes by a tracing method as indicated in Fig. 1, with images obtained at 
the end diastolic phase of the cardiac cycle.  The left ventricular ejection fraction （LVEF） 
was measured using a biplane Modied Simpson method.
Catheter ablation procedure
　All patients provided written informed consent to undertake the PVI, which was per-
formed under electro-anatomical mapping （Carto ; Biosense-Webster, Diamond Bar, CA）. 
Two circular mapping catheters （Lasso ; Biosense-Webster） and a 4-mm or 8-mm tip abla-
tion catheter （Navistar ; Biosense-Webster） were introduced into the LA by the Brocken-
brough technique REF.  The left- and right-sided PVs were each encircled with RF lesions 
0.5-1.0 cm from the ostia.  The end point of the ablation procedure was dened as the 
electrical disconnection of all 4 PVs from the LA.  No additional ablation lines or CAFE 
A） before PVI B） After PVI （12-month follow-up）
Fig. 1.  The measurement of the atrial areas
The left panel shows the 4 chamber echocardiographic image before the PVI and the right panel 
shows the 4 chamber echocardiographic image after the PVI （12-month follow-up）. Both atrial sizes 
were reduced after the PVI.
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ablation was added in these study cases.  Patients who underwent an RA isthmus ablation 
were excluded from this study.
Statistical analysis
　The continuous variables are reported as mean ± SD and categorical variables as propor-
tions.  Student’s t-test was used to evaluate changes in the echocardiographic parameters. 
All P values were two-sided, and a P value of less than 0.05 was considered to indicate sta-
tistical signicance.  Although the number of cases examined was small, the data exhibited a 
normal distribution.
Results
　Disconnection of all 4 PVs was achieved by the ablation procedure in all patients.  Dur-
ing the follow up, AF recurrence was documented in 7 patients （41.2%）, comprising 5 with 
PER-AF and 2 with PAF.  The recurrence occurred within 3 months after the PVI in both 
groups.  No cases went into chronic AF during follow-up.
　The echocardiographic findings at baseline and after the PVI are detailed in Table 2. 
Both LA and RA sizes were reduced after the PVI compared to baseline values （LA : 
25.4 ± 2.9 cm2 vs. 23.2 ± 3.6 ; RA : 21.2 ± 2.9 cm2 vs. 18.1 ± 3.0）.  Table 2 indicates the degree 
of atrial size reduction in all cases, and shows a greater reduction in RA than LA size 
（14.9% vs. 8.7%, P＜ 0.05）.  Considering the variability in the examinations and reduction 
rate in all cases, we then examined whether atrial size was reduced by at least 10% more 
than the sizes at baseline ; size reduction after the PVI was 10% or greater in 13/17 （76%） 
cases in the RA, and 8/17 cases （47%） in the LA.  The LVEF did not signicantly change 
after the PVI compared to baseline （data not shown）.  With respect to AF type, the 
atrial size was signicantly reduced in PAF cases, but not in the PER-AF cases （Table 3）. 
Finally, a reduction in atrial size was observed only in cases with no AF recurrence （Table 
3）.
Discussion
　The occurrence and perpetuation of AF cause electrical and structuring remodeling of 
heart atria, and restoring and maintaining sinus rhythm are expected to improve remodel-
ing 3）.  Reduced LA size after PVI for AF was found in some studies 4-10）; however, few 
reports have assessed changes in RA size 9, 10）.
　The present study examined and compared the changes in both RA and LA size follow-
ing PVI.  Although both atria showed reduced size following the PVI, the RA size was 
more reduced than the LA size, which is consistent with other reports despite the small 
patient number in our study 9, 10）.
　Verma et al 8） reported that PVI improved LA systolic function and reduced LA size 
using echocardiography and computed tomography 8）, with no mention of RA function.  In 
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Table 2.  Results of parameter at baseline and after PVI
The change of LA area after PVI The change of RA area after PVI
Pre ABL Post ABL Decrease rate Pre ABL Post ABL Decrease rate
Patients （cm2） （cm2） （％） （cm2） （cm2） （％） AF type Recurrence
A
B
c
d
e
f
g
h
i
j
k
l
m
n
o
p
q
23
20
26
25
26
20
26
23
29
27
25
28
28
26
24
31
26
22
15
20
22
19
22
26
24
22
30
25
25
28
24
23
27
20
4.3
25.0
23.1
12.0
26.9
-10
0
-4.3
24.3
-11.1
0
10.7
0
7.6
4.1
12.9
23.1
22
16
21
19
23
18
21
21
16
21
25
24
25
19
22
26
21
18
13
17
19
16
17
18
21
13
17
22
20
24
16
18
22
16
18.2
18.8
19.0
0
30.4
5.6
14.3
0
18.7
19.0
12.0
16.7
4.0
15.7
18.2
15.4
23.8
PAF
PER-AF
PER-AF
PAF
PAF
PAF
PAF
PER-AF
PAF
PER-AF
PAF
PER-AF
PER-AF
PAF
PAF
PAF
PAF
＋
＋
＋
－
－
－
－
－
－
＋
＋
＋
＋
－
－
－
－
Average 25.4 ± 2.9 23.2 ± 3.6 8.7 ± 12.4＊ 21.2 ± 2.9 18.1 ± 3.0 14.9 ± 8.1＊
Above 10％ reduction after PVI   8/17（47％） 13/17 （76％）＊ ＊P＜ 0.05
Table 2 shows the results of the parameters before and after the PVI. Both the left and right atrial areas 
were significantly reduced after the PVI. A reduction in the LA area of greater than 10% before the PVI was 
observed in 8/17 cases, whereas a decrease in the RA area of greater than 10% was observed in 13/17 cases 
（P＜ 0.05）. 
Table 3.  The change in the atrial size of AF type and AF recurrence
Variable PAF
（n＝ 11）
PAR-AF
（n＝ 6）
LA area（cm2）
RA area（cm2）
Left ventricular EF（％）
25.5 ± 2.9 → 22.9 ± 2.4＊
21.1 ± 3.0 → 17.7 ± 2.6＊
64.3 ± 10.9 → 66.0 ± 11.0
25.3 ± 3.2 → 23.7 ± 5.5
21.3 ± 3.1 → 18.7 ± 3.8
56.3 ± 15.7 → 60.3 ± 13.0
Variable Non-recurrence group
（n＝ 10）
Recurrence group
 （n＝ 7）
LA area（cm2）
RA area（cm2）
Left ventricular EF（％）
25.6 ± 3.0 → 22.9 ± 2.5＊
20.6 ± 2.8 → 17.6 ± 2.6＊
64.6 ± 11.0 → 66.3 ± 11.5
25.3 ± 2.9 → 25.6 ± 5.1
22.0 ± 3.2 → 18.7 ± 3.6
57.0 ± 15.0 → 61.5 ± 12.5
＊P＜ 0.05
Table 3 shows the change in the atrial size of AF type （PAF vs. PER-AF） and AF 
recurrence （non-recurrence vs. recurrence）, the atrial size was reduced in PAF cases, 
but the reduction was insignificant in the PER-AF cases. Concerning AF recurrences, 
a reduction in the atrial size was observed in the non-recurrence cases, but not in 
the recurrence cases. LV-EF did not change between the two groups.
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contrast, Wylie et al 10） found no improvement in LA function following PVI.  Using mag-
netic resonance imaging, these authors found that PVI caused the LA volume to decrease 
by 15%, while LA-EF decreased by 14%.  The RA volume decreased by 13% and the RA-
EF increased by 5% after the PVI.  They suggested an association between the degree of 
LA-EF decrease and the LA scar volume.  It is speculated that the LA size was reduced 
due to the AF episodes ceasing, but the RA may reduce more than the LA because it 
does not receive ablation procedure.
　Concerning the atrial size change and AF type or AF recurrence, most of the non-
recurrence cases （9/11） were PAF patients, while most cases of recurrence （5/6） occurred 
among the among the PER-AF cases.  Our ndings may indicate only the effects of AF 
recurrence.
Limitations
　Our study consisted of a small number of cases, so that we were not able to closely 
examine the association between the atrial size changes and the basic disease, kinds of 
medications, AF recurrence, and type of AF.  Further examination using a large number of 
cases needs to be carried out to clarify the effects of these factors on the atrial size.  This 
should include changes in atrial function, that is, the amplitude of the atrial kick or atrial 
ejection fraction.  Further examination is also needed using 3D echocardiography, because of 
the limitations with 2D imaging for accurately detecting changes in atrial volume.
Conclusion
　This study demonstrated size reduction in both left and right atria following PVI, with the 
RA size more prone to reduction than the LA size.
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